Results
1 -
10 of
11DNA and Histone Methylation in Hematopoietic Malignancy, DNA and Histone Methylation as Cancer Targets Immunomodulatory activity of SGI-110, a 5-aza-2u2032-deoxycytidine-containing demethylating dinucleotide, Cancer Immunology, Immunotherapy Fourteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 13u201315, 2016, Cancer Immunology, Immunotherapy Incorporating DNA Methyltransferase Inhibitors (DNMTis) in the Treatment of Genitourinary Malignancies: A Systematic Review, Targeted Oncology Management of Relapsed/Refractory Acute Myeloid Leukemia in the Elderly: Current Strategies and Developments, Drugs & Aging Akute myeloische Leuk??mie: ??ltere profitieren von einem Decitabin-Prodrug, Im Focus Onkologie Precision therapy for acute myeloid leukemia, Journal of Hematology & Oncology SPIRE u2013 combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trial, Trials Immunomodulatory activity of SGI-110: a basis for novel chemo-immunotherapeutic combinations in cancer treatment, Journal for ImmunoTherapy of Cancer Discovery of imatinib-responsive FIP1L1-PDGFRA mutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemia, Journal of Hematology & Oncology